Where CXCL13 is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Multiple Sclerosis | ↕ inconsistent | postmortem MS cases with low levels of meningeal inflammation and GM demyelination | high levels of meningeal inflammation and GM demyelination | Magliozzi et al. 2018 |
Frequently asked questions
In which conditions is CXCL13 altered?
In the OSMF atlas CXCL13 is reported in Multiple Sclerosis. It is mixed in 1 across 1 entries.
Is there a standard clinical test for CXCL13?
The atlas entries for CXCL13 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal CXCL13 result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.